Three independent predictors of mortality from the aforementioned analyses (SERPINI1 expression, age, and tumor grade) were combined to create a prognostic nomogram that was then tested and validated using TCGA data to better predict the prognosis of glioma patients in the clinic (Figure 5B). This evidence concerns the gene SERPINI1 and neoplasm.